Overview
Junqing Xu practices in Tianjin, China. Xu is rated as an Advanced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Their top areas of expertise are Myelofibrosis, Splenomegaly, Essential Thrombocythemia, and Polycythemia Vera.
Their clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MyelofibrosisXu isDistinguished. Learn about Myelofibrosis.
- Advanced
- Essential Thrombocythemia
- Myeloproliferative Neoplasms (MPN)
- Polycythemia VeraXu isAdvanced. Learn about Polycythemia Vera.
- SplenomegalyXu isAdvanced. Learn about Splenomegaly.
- Experienced
- Acute Myeloid Leukemia (AML)
- Blood ClotsXu isExperienced. Learn about Blood Clots.
- LeukemiaXu isExperienced. Learn about Leukemia.
- Lung CancerXu isExperienced. Learn about Lung Cancer.
- Philadelphia-Negative Chronic Myeloid Leukemia